Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein

被引:130
作者
Ayesh, S [1 ]
Shao, YM [1 ]
Stein, WD [1 ]
机构
[1] HEBREW UNIV JERUSALEM,SIBERMAN INST LIFE SCI,IL-91904 JERUSALEM,ISRAEL
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1996年 / 1316卷 / 01期
关键词
P-glycoprotein; modulator interaction; cooperativity; interaction; competitive; non-competitive; multidrug resistance;
D O I
10.1016/0925-4439(96)00008-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We measured the effects of individual modulators and of pairs of modulators of the multidrug resistance pump, P-glycoprotein, on the accumulation of labelled daunomycin into multidrug-resistant P388 leukemia cells at 37 degrees C and developed a kinetic analysis which enables such data to be modelled in terms of co-operative, competitive or non-competitive interaction between pairs of modulators. The modulators verapamil, cyclosporin and trifluoperazine interacted with P-glycoprotein as single molecules, while vinblastine, mefloquine, dipyridamole, tamoxifen and quinidine displayed Hill numbers close to 2, suggesting that pairs of modulator molecules need to act together in order to bring about effective reversal of P-glycoprotein. When the modulators were presented to P-glycoprotein in pairs, we found examples of both competitive and non-competitive behaviour. We interpret these results on a model in which two modulatory sites exit on the MDR pump. To one of these, mefloquine, vinblastine and tamoxifen bind preferentially; to the other, verapamil, dipyridamole, trifluoperazine and quinidine bind (but mefloquine and tamoxifen only weakly if at all). Cyclosporin A can interact with both sites.
引用
收藏
页码:8 / 18
页数:11
相关论文
共 41 条
[1]  
ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
[2]   PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS [J].
AMBUDKAR, SV ;
LELONG, IH ;
ZHANG, JP ;
CARDARELLI, CO ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8472-8476
[3]   CYCLOSPORINE-A AND VERAPAMIL HAVE DIFFERENT EFFECTS ON ENERGY-METABOLISM IN MULTIDRUG-RESISTANT TUMOR-CELLS [J].
BROXTERMAN, HJ ;
PINEDO, HM ;
SCHUURHUIS, GJ ;
LANKELMA, J .
BRITISH JOURNAL OF CANCER, 1990, 62 (01) :85-88
[4]   ACTIVE OUTWARD TRANSPORT OF DAUNOMYCIN IN RESISTANT EHRLICH ASCITES TUMOR-CELLS [J].
DANO, K .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 323 (03) :466-483
[5]   THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE [J].
ENDICOTT, JA ;
LING, V .
ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 :137-171
[6]   COMPARISON OF THE MEMBRANE-TRANSPORT OF ANTHRACYCLINE DERIVATIVES IN DRUG-RESISTANT AND DRUG-SENSITIVE K562 CELLS [J].
FREZARD, F ;
GARNIERSUILLEROT, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 196 (02) :483-491
[7]   BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427
[8]   MAMMALIAN MULTIDRUG RESISTANCE GENE - COMPLETE CDNA SEQUENCE INDICATES STRONG HOMOLOGY TO BACTERIAL TRANSPORT PROTEINS [J].
GROS, P ;
CROOP, J ;
HOUSMAN, D .
CELL, 1986, 47 (03) :371-380
[9]  
HU XF, 1990, CANCER RES, V50, P2953
[10]   SYNERGISTIC EFFECT OF CYCLOSPORINE-A AND VERAPAMIL IN OVERCOMING VINCRISTINE RESISTANCE OF MULTIDRUG-RESISTANT CULTURED HUMAN LEUKEMIA-CELLS [J].
ISHIDA, Y ;
SHIMADA, Y ;
SHIMOYAMA, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 1990, 81 (08) :834-841